An optogenetic upgrade for the Tet-OFF system

Biotechnology and Bioengineering

Volumn 112, Issue 7, 2015, Pages 1483-1487

  Müller, Konrad ^a   Zurbriggen, Matias D ^a   Weber, Wilfried ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Gene switch; Inducible expression; Optogenetics; TET system

Indexed keywords

CELL CULTURE; GENES; MAMMALS;

GENE SWITCH; INDUCIBLE EXPRESSION; OPTOGENETICS; SPATIO-TEMPORAL RESOLUTION; TET SYSTEM; TRANSACTIVATION DOMAIN; TRANSGENE EXPRESSION; TRANSGENIC ORGANISMS;

GENE EXPRESSION;

MEDIATOR COMPLEX; PROTEIN VP16; PROTEIN VP64; SYNTHETIC DNA; TETRACYCLINE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BLUE LIGHT; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE SWITCHING; HEK293 CELL LINE; HUMAN; HUMAN CELL; ILLUMINATION; OPTOGENETICS; PROTEIN DEGRADATION; REPORTER GENE; TET OFF SYSTEM; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSGENE; BIOTECHNOLOGY; CELL LINE; GENE EXPRESSION REGULATION; LIGHT; PROCEDURES; RADIATION RESPONSE;

MAMMALIA;

BIOTECHNOLOGY; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; LIGHT; OPTOGENETICS; TRANSGENES;

EID: 84929944636     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25562     Document Type: Article

References (22)

1. Bacchus W, Lang M, El-Baba MD, Weber W, Stelling J, Fussenegger M. 2012. Synthetic two-way communication between mammalian cells. Nat Biotechnol 30(10):991-996.
2. Beerli RR, Segal DJ, Dreier B, Barbas CF, III. 1998. Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci USA 95(25):14628-14633.
3. Bonger KM, Rakhit R, Payumo AY, Chen JK, Wandless TJ. 2014. General method for regulating protein stability with light. ACS Chem Biol 9(1):111-115.
4. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE. 2000. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18(11):1203-1208.
5. Gautier A, Gauron C, Volovitch M, Bensimon D, Jullien L, Vriz S. 2014. How to control proteins with light in living systems. Nat Chem Biol 10(7):533-541.
6. Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M. 2009. Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin. Proc Natl Acad Sci USA 106(26):10638-10643.
7. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89(12):5547-5551.
8. Milbradt AG, Kulkarni M, Yi TF, Takeuchi K, Sun ZYJ, Luna RE, Selenko P, Naar AM, Wagner G. 2011. Structure of the VP16 transactivator target in the mediator. Nat Struct Mol Biol 18(4):410-U36.
9. Mitta B, Rimann M, Ehrengruber MU, Ehrbar M, Djonov V, Kelm J, Fussenegger M. 2002. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 30(21):e113.
10. Muller K, Engesser R, Schulz S, Steinberg T, Tomakidi P, Weber CC, Ulm R, Timmer J, Zurbriggen MD, Weber W. 2013. Multi-chromatic control of mammalian gene expression and signaling. Nucleic Acids Res 41(12):e124.
11. Muller K, Engesser R, Timmer J, Zurbriggen MD, Weber W. 2014a. Orthogonal optogenetic triple-gene control in Mammalian cells. ACS Synth Biol 3(11):796-801.
12. Muller K, Naumann S, Weber W, Zurbriggen MD. 2014b. Optogenetics for gene expression in mammalian cells. Biol Chem. 396(2):145-52.
13. Muller K, Zurbriggen MD, Weber W. 2014c. Control of gene expression using a red- and far-red light-responsive bi-stable toggle switch. Nat Protoc 9(3):622-632.
14. Schonig K, Bujard H, Gossen M. 2010. The power of reversibility regulating gene activities via tetracycline-controlled transcription. Methods Enzymol 477:429-453.
15. Seipel K, Georgiev O, Schaffner W. 1992. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J 11(13):4961-4968.
16. Urlinger S, Helbl V, Guthmann J, Pook E, Grimm S, Hillen W. 2000. The p65 domain from NF-kappaB is an efficient human activator in the tetracycline-regulatable gene expression system. Gene 247(1-2):103-110.
17. Weber W, Fussenegger M. 2011. Molecular diversity-the toolbox for synthetic gene switches and networks. Curr Opin Chem Biol 15(3):414-420.
18. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M. 2002. Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 20(9):901-7.
19. Weitzman M, Hahn KM. 2014. Optogenetic approaches to cell migration and beyond. Curr Opin Cell Biol 30C:112-120.
20. Yamit-Hezi A, Dikstein R. 1998. TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. EMBO J 17(17):5161-5169.
21. Yamit-Hezi A, Nir S, Wolstein O, Dikstein R. 2000. Interaction of TAFII105 with selected p65/RelA dimers is associated with activation of subset of NF-kappa B genes. J Biol Chem 275(24):18180-18187.
22. Yang FJ, DeBeaumont R, Zhou S, Naar AM. 2004. The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc Natl Acad Sci USA 101(8):2339-2344.